ATE444080T1 - Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien - Google Patents

Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien

Info

Publication number
ATE444080T1
ATE444080T1 AT98963173T AT98963173T ATE444080T1 AT E444080 T1 ATE444080 T1 AT E444080T1 AT 98963173 T AT98963173 T AT 98963173T AT 98963173 T AT98963173 T AT 98963173T AT E444080 T1 ATE444080 T1 AT E444080T1
Authority
AT
Austria
Prior art keywords
substituted
alkyls
cycloalkyls
aryls
heteroalkyls
Prior art date
Application number
AT98963173T
Other languages
English (en)
Inventor
Richard Greenwald
Annapurna Pendri
Yun Choe
Samuel Zalipsky
Original Assignee
Enzon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzon Inc filed Critical Enzon Inc
Priority claimed from PCT/US1998/026565 external-priority patent/WO1999030727A1/en
Application granted granted Critical
Publication of ATE444080T1 publication Critical patent/ATE444080T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
AT98963173T 1997-12-17 1998-12-14 Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien ATE444080T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99243597A 1997-12-17 1997-12-17
US09/183,557 US6180095B1 (en) 1997-12-17 1998-10-30 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
PCT/US1998/026565 WO1999030727A1 (en) 1997-12-17 1998-12-14 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents

Publications (1)

Publication Number Publication Date
ATE444080T1 true ATE444080T1 (de) 2009-10-15

Family

ID=25538340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98963173T ATE444080T1 (de) 1997-12-17 1998-12-14 Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien

Country Status (4)

Country Link
US (1) US6180095B1 (de)
EP (1) EP1897561A1 (de)
AT (1) ATE444080T1 (de)
DE (1) DE69841206D1 (de)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
AU1825299A (en) * 1997-12-17 1999-07-05 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
DK1121382T3 (da) 1998-10-16 2006-11-13 Biogen Idec Inc Interferon-beta-fusionsproteiner og deres anvendelser
PT1121156E (pt) * 1998-10-16 2006-05-31 Biogen Idec Inc Conjugados de polimeros de interferao-beta-1a e as suas utilizacoes
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
US7303760B2 (en) * 1999-04-23 2007-12-04 Alza Corporation Method for treating multi-drug resistant tumors
DE60030965T2 (de) * 1999-04-23 2007-05-24 Alza Corp., Mountain View Konjugate enthaltend eine spaltbare bindung zur anwendung in einem liposom
US7238368B2 (en) * 1999-04-23 2007-07-03 Alza Corporation Releasable linkage and compositions containing same
US6713454B1 (en) 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs
CA2412162A1 (en) * 2000-07-12 2002-01-17 Gryphon Therapeutics, Inc. Chemokine receptor modulators, production and use
US7118737B2 (en) 2000-09-08 2006-10-10 Amylin Pharmaceuticals, Inc. Polymer-modified synthetic proteins
EE200300089A (et) * 2000-09-08 2005-02-15 Gryphon Therapeutics, Inc. Sünteetilised erütropoeesi stimuleerivad valgud, nende valmistamismeetodid ning kasutamine
WO2002066066A1 (en) * 2001-02-20 2002-08-29 Enzon, Inc. Terminally-branched polymeric linkers and polymeric conjugates containing the same
EP1379257B1 (de) * 2001-03-23 2009-08-12 Enzon, Inc. Prodrugs von krebsmitteln mit substituierten aromatischen säuren
US20040077835A1 (en) * 2001-07-12 2004-04-22 Robin Offord Chemokine receptor modulators, production and use
CN101700401B (zh) * 2002-01-18 2013-08-14 比奥根艾迪克Ma公司 具有用于共轭生物活性化合物的部分的聚亚烷基二醇
AU2003253890A1 (en) * 2002-07-12 2004-02-02 Biomarin Pharmaceutical Inc. The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates
US20040062748A1 (en) * 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040152769A1 (en) * 2002-11-09 2004-08-05 Ekwuribe Nnochiri Nkem Modified carbamate-containing prodrugs and methods of synthesizing same
AU2003295432A1 (en) * 2002-11-12 2004-06-03 Enzon Pharmaceuticals, Inc. Prodrugs of vancomycin with hydrolysis resistant polymer linkers
US8034900B2 (en) * 2002-12-30 2011-10-11 Amylin Pharmaceuticals, Inc. Water-soluble thioester and selenoester compounds and methods for making and using the same
EP1597299A2 (de) * 2003-02-19 2005-11-23 Pharmacia Corporation Mit oxalatestern aktivierte carbonatester von polyethylenglykol
US7332164B2 (en) * 2003-03-21 2008-02-19 Enzon Pharmaceuticals, Inc. Heterobifunctional polymeric bioconjugates
NZ542687A (en) * 2003-04-13 2010-02-26 Enzon Pharmaceuticals Inc Polymeric oligonucleotide prodrugs
US20050249697A1 (en) * 2003-09-24 2005-11-10 Uhrich Kathryn E Compositions and methods for the inhibition of bone growth and resorption
WO2005067644A2 (en) * 2004-01-07 2005-07-28 Ambit Biosciences Corporation Conjugated small molecules
EP1807436B1 (de) * 2004-10-25 2014-06-18 Intezyne Technologies Inc. Heterobifunktionelles poly(ethylenglykol) und seine verwendungen
WO2006105993A2 (en) 2005-04-05 2006-10-12 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Method for shielding functional sites or epitopes on proteins
US20070185135A1 (en) * 2005-12-30 2007-08-09 Pharmaessentia Corp. Drug-Polymer Conjugates
GB0604187D0 (en) * 2006-03-02 2006-04-12 Fusion Antibodies Ltd Peptide and uses thereof
CA2861601A1 (en) 2006-04-27 2007-11-08 Intezyne Technologies, Inc. Poly (ethylene glycol) containing chemically disparate endgroups
AU2007248680C1 (en) 2006-05-02 2014-01-23 Allozyne, Inc. Non-natural amino acid substituted polypeptides
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
GB0611405D0 (en) * 2006-06-09 2006-07-19 Univ Belfast FKBP-L: A novel inhibitor of angiogenesis
US20090156629A1 (en) * 2006-06-09 2009-06-18 Enzon Pharmaceuticals, Inc. Indenoisoquinoline-releasable polymer conjugates
WO2008011234A2 (en) * 2006-06-30 2008-01-24 Enzon Pharmaceuticals, Inc. Recombinant host for producing l-asparaginase ii
AU2007296055A1 (en) * 2006-09-15 2008-03-20 Enzon Pharmaceuticals, Inc. Polymeric conjugates containing positively-charged moieties
US7985783B2 (en) 2006-09-21 2011-07-26 The Regents Of The University Of California Aldehyde tags, uses thereof in site-specific protein modification
CA2664271A1 (en) * 2006-11-27 2008-06-12 Enzon Pharmaceuticals, Inc. Polymeric short interfering rna conjugates
TW200835514A (en) * 2006-12-29 2008-09-01 Enzon Pharmaceuticals Inc Use of adenosine deaminase for treating pulmonary disease
ES2569940T3 (es) 2007-04-20 2016-05-13 Sigma-Tau Rare Disease Ltd Adenosina desaminasa recombinante estable
ES2507508T3 (es) * 2007-04-20 2014-10-15 Sigma-Tau Rare Diseases S.A. Terapia anticancerígena enzimática
CA2693616A1 (en) * 2007-07-11 2009-01-15 Enzon Pharmaceuticals, Inc. Polymeric drug delivery system containing a multi-substituted aromatic moiety
JP2010533233A (ja) * 2007-07-11 2010-10-21 エンゾン ファーマシューティカルズ,インコーポレーテッド 芳香族アリル酸を含むポリマー性薬剤送達システム
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
EP2445343B1 (de) 2009-06-25 2021-08-04 Alkermes Pharma Ireland Limited Prodrugs aus nh-säureverbindungen
SI2445502T1 (sl) 2009-06-25 2017-10-30 Alkermes Pharma Ireland Limited Heterociklične spojine za zdravljenje neuroloških in psiholoških motenj
WO2011084851A1 (en) * 2010-01-07 2011-07-14 Alkermes, Inc. Asenapine produrugs
US20110166156A1 (en) * 2010-01-07 2011-07-07 Alkermes, Inc. Prodrugs for the Treatment of Schizophrenia and Bipolar Disease
CA2804034C (en) 2010-01-07 2016-12-13 Laura Cook Blumberg Prodrugs of heteraromatic compounds
WO2011084849A1 (en) * 2010-01-07 2011-07-14 Alkermes, Inc. Diaryldiazepine prodrugs for the treatment of neurological and psychological disorders
ES2647361T3 (es) * 2010-01-07 2017-12-21 Alkermes Pharma Ireland Limited Profármacos de sales de amonio cuaternario
WO2011163594A2 (en) 2010-06-24 2011-12-29 Alkermes, Inc. Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
AU2011325990C1 (en) 2010-11-12 2017-06-08 Nektar Therapeutics Conjugates of an IL-2 moiety and a polymer
US8846941B2 (en) 2010-12-13 2014-09-30 Quiapeg Ab Functionalized polymers
JP5941926B2 (ja) * 2010-12-29 2016-06-29 アローヘッド リサーチ コーポレイション 酵素感受性連結を有するインビボポリヌクレオチド送達結合体
LT2685979T (lt) 2011-03-18 2016-12-12 Alkermes Pharma Ireland Limited Injekcinės farmacinės kompozicijos, apimančios vandenyje netirpų antipsichotiką, sorbitano lauratą ir polisorbatą 20
DE102011118029A1 (de) 2011-06-20 2012-12-20 Universität Leipzig Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung
JP6208658B2 (ja) 2011-07-05 2017-10-04 バイオアシス テクノロジーズ インコーポレイテッド p97−抗体結合体および使用方法
AU2012351747B2 (en) 2011-12-15 2016-05-12 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
NZ630643A (en) 2012-03-19 2017-08-25 Alkermes Pharma Ireland Ltd Pharmaceutical compositions comprising fatty acid esters
CA2867123C (en) 2012-03-19 2021-02-16 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising water-insoluble antipsychotic agents and glycerol esters
EP2827866B1 (de) 2012-03-19 2023-05-03 Alkermes Pharma Ireland Limited Pharmazeutische zusammensetzungen mit benzylalkohol
CA2876315C (en) 2012-06-12 2021-05-25 Marek Kwiatkowski Conjugates of biologically active molecules to functionalized polymers
CA3140358A1 (en) 2012-07-31 2014-02-06 Bioasis Technologies, Inc. Dephosphorylated lysosomal storage disease proteins and methods of use thereof
EP2897592B1 (de) 2012-09-19 2020-02-19 Alkermes Pharma Ireland Limited Pharmazeutische zusammensetzungen mit verbesserter lagerstabilität
US9605078B2 (en) 2012-11-16 2017-03-28 The Regents Of The University Of California Pictet-Spengler ligation for protein chemical modification
US9310374B2 (en) 2012-11-16 2016-04-12 Redwood Bioscience, Inc. Hydrazinyl-indole compounds and methods for producing a conjugate
CA2906003C (en) 2013-03-13 2021-07-06 Bioasis Technologies Inc. Fragments of p97 and uses thereof
EP3038657A2 (de) 2013-08-28 2016-07-06 Bioasis Technologies Inc. Cns-gerichtete konjugate mit modifizierten fc-regionen und verfahren zur verwendung davon
CN105744935B (zh) 2013-11-27 2022-09-30 雷德伍德生物科技股份有限公司 肼基-吡咯并化合物及用于生成缀合物的方法
CN107073119A (zh) 2014-02-26 2017-08-18 德克萨斯大学系统董事会 用于操控细胞酸中毒的硝基苯甲醛质子的释放
RU2688233C2 (ru) 2014-03-20 2019-05-21 Алкермес Фарма Айэленд Лимитед Препараты арипипразола, имеющие повышенные скорости впрыска
DK3207130T3 (da) 2014-10-14 2019-11-11 Halozyme Inc Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme
JP7109427B2 (ja) 2016-06-01 2022-07-29 セルヴィエ アイピー ユーケー リミテッド ポリアルキレンオキシド-アスパラギナーゼの製剤ならびにその製造法および使用法
KR102345175B1 (ko) 2016-11-14 2021-12-31 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
CN108727208B (zh) * 2017-03-07 2020-06-30 天津键凯科技有限公司 一种连接子化合物、聚乙二醇-连接子结合物及其衍生物和聚乙二醇-连接子-药物结合物
DK3592393T3 (da) 2017-03-10 2022-03-07 Quiapeg Pharmaceuticals Ab Frigørbare konjugater
JP7022328B2 (ja) 2017-03-30 2022-02-18 日油株式会社 自壊性アセタールリンカーを有する親水性ポリマー誘導体及びそれを用いた複合体
JP7338873B2 (ja) 2017-07-19 2023-09-05 ユニケリス・リミテッド 強皮症関連血管障害を治療または改善するための組成物および方法
EP4257198A3 (de) 2017-08-22 2023-10-18 Dynavax Technologies Corporation Alkylkettenmodifizierte imidazochinolin-derivate als tlr7/8-agonisten und verwendungen davon
CN114668852A (zh) * 2017-09-30 2022-06-28 天津键凯科技有限公司 一种聚乙二醇-多肽和蛋白类药物的结合物
CN109589415B (zh) 2017-09-30 2022-02-18 天津键凯科技有限公司 一种聚乙二醇-多肽和蛋白类药物的结合物
EP3710059A1 (de) 2017-11-14 2020-09-23 Dynavax Technologies Corporation Spaltbare konjugate von tlr7/8-agonist-verbindungen, verfahren zur herstellung und verwendungen davon
US11492493B2 (en) 2017-12-26 2022-11-08 Becton, Dickinson And Company Deep ultraviolet-excitable water-solvated polymeric dyes
CN112423754A (zh) 2018-03-05 2021-02-26 奥克梅斯制药爱尔兰有限公司 阿立哌唑的给药策略
EP3775052B1 (de) 2018-03-30 2024-06-05 Becton, Dickinson and Company Wasserlösliche polymere farbstoffe mit seitenständigen chromophoren
WO2020023300A1 (en) 2018-07-22 2020-01-30 Bioasis Technologies, Inc. Treatment of lymmphatic metastases
BR112021004689A2 (pt) 2018-09-12 2021-06-08 Quiapeg Pharmaceuticals Ab conjugados glp-1 liberáveis
EP3909612A1 (de) 2020-05-12 2021-11-17 Life Science Inkubator Betriebs GmbH & Co. KG Zusammensetzung von nanopartikeln
US20210355468A1 (en) 2020-05-18 2021-11-18 Bioasis Technologies, Inc. Compositions and methods for treating lewy body dementia
US20210393787A1 (en) 2020-06-17 2021-12-23 Bioasis Technologies, Inc. Compositions and methods for treating frontotemporal dementia
EP3954393A1 (de) 2020-08-13 2022-02-16 Bioasis Technologies Inc. Kombinationstherapien zur verabreichung über die blut-hirn-schranke hinweg
EP4155349A1 (de) 2021-09-24 2023-03-29 Becton, Dickinson and Company Wasserlösliche gelbe grünabsorbierende farbstoffe
WO2024007016A2 (en) 2022-07-01 2024-01-04 Beckman Coulter, Inc. Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives
WO2024044327A1 (en) 2022-08-26 2024-02-29 Beckman Coulter, Inc. Dhnt monomers and polymer dyes with modified photophysical properties

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JP2958019B2 (ja) 1988-05-06 1999-10-06 住友製薬株式会社 ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
FR2676058B1 (fr) 1991-04-30 1994-02-25 Hoechst Lab Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers.
US5614549A (en) * 1992-08-21 1997-03-25 Enzon, Inc. High molecular weight polymer-based prodrugs
US5382657A (en) * 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
JP3026133B2 (ja) * 1992-11-05 2000-03-27 コニカ株式会社 ハロゲン化銀写真感光材料
US5349001A (en) 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
US5321095A (en) 1993-02-02 1994-06-14 Enzon, Inc. Azlactone activated polyalkylene oxides
ES2148259T3 (es) * 1993-09-22 2000-10-16 Hoechst Ag Pro-profarmacos, su produccion y uso.
US5840900A (en) * 1993-10-20 1998-11-24 Enzon, Inc. High molecular weight polymer-based prodrugs
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5605976A (en) 1995-05-15 1997-02-25 Enzon, Inc. Method of preparing polyalkylene oxide carboxylic acids
US5672584A (en) 1995-04-25 1997-09-30 The University Of Kansas Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
DE69533615T2 (de) 1995-06-27 2005-10-13 Pharmachemie B.V. Anthracyclin Prodrugs, Verfahren zu deren Herstellung und deren Verwendung in der selektiven Chemotherapie
AU739028B2 (en) 1996-09-27 2001-10-04 Bristol-Myers Squibb Company Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents

Also Published As

Publication number Publication date
EP1897561A1 (de) 2008-03-12
DE69841206D1 (de) 2009-11-12
US6180095B1 (en) 2001-01-30

Similar Documents

Publication Publication Date Title
ATE444080T1 (de) Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien
AU2021299A (en) Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
DK0581452T3 (da) Vaskemiddelsammensætninger med polysuccinimid
ATE102966T1 (de) Blockcopolyester mit verzweigten hydrophilen endgruppen, verwendbar als schmutzentfernungsmittel in waschmittelzusammensetzungen.
CA2312975A1 (en) Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
DE69739853D1 (de) Synthetische rapamycinderivate als multimerisierende wirkstoffe für chimere proteine mit von immunophilin abgeleiteten domänen
DE59105815D1 (de) 1,4,7,10-Tetraazacyclododecan-butyltriole, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel.
CY1105811T1 (el) Ενωσεις ενισχυτη ταξολης
FR2774899B1 (fr) Composition cosmetique a base de polyurethannes associatifs et de polymeres non ioniques a chaines grasses
FI924969A (fi) Latenta kedoeverfoeringsmedel av tiolmerkaptantyp och deras anvaendning vid syntes av polymerer
DK0934080T3 (da) 1,3-Bis-(N-lactamyl)propaner og deres farmaceutiske og kosmetiske anvendelse
ES2056146T3 (es) Monopersulfatos de acidos amino-(poli)percarboxilicos.
DE60233315D1 (de) Prodrugs von krebsmitteln mit substituierten aromatischen säuren
BR8906510A (pt) Mistura de polimeros,recipiente e processo para a protecao de materiais dos gases ambientais
ATE203510T1 (de) Multifunktionelle vinylcyclopropan-derivate
DE69605838T2 (de) Pigmentkompositionen von 3,6-di(4-biphenylyl)-1,4-diketopyrrolo(3,4)-pyrrol
ATE395382T1 (de) Härtbare polymerverbindung
AR034463A1 (es) Articulos polimeros estabilizados frente a la luz y metodos para la obtencion de los mismos.
DE60210140D1 (de) Verfahren zur herstellung von polycarbonat
DE60112009D1 (de) Verfahren zur Herstellung von 3-Arylbenzofuran-2-onen
FI963055A (fi) Kondensaatio- ja additiopolymeereja, jotka sisältävät N,N'-sillan sisältäviä bis(tetrametyylipiperidinyylioksi)-ryhmiä
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
ATE154345T1 (de) Indol-sulfonamide als antitumormittel
DE50213160D1 (de) Verfahren zur Herstellung von Pyrrolen
ATE247126T1 (de) Olefinpolymerisation in gegenwart von dialcoxysilacyclohexanen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties